
- Volume 0 0
Bifantis Effective for Women with IBS
The probiotic (or "good" bacteria) Bifidobacteriuminfantis 35624 (Bifantis) hasproven effective in the management ofirritable bowel syndrome (IBS) in women.The randomized, double-blind, doserangingstudy of 362 women with IBSreceived either a Bifantis capsule orplacebo once a day for 4 weeks. Thepatients, who ranged in age from 18 to65 years, recorded any abdominal pain,bloating, incomplete evacuation, strainingat stool, flatulence, and bowel habitsatisfaction. They also assessed anyrelief of IBS symptoms. After 4 weeks,Bifantis had proved "significantly superiorto placebo" for the relief of abdominalpain, bloating, incomplete evacuation,straining, and flatulence. No significantadverse events were recorded. The studyappeared in the July 2006 issue of theAmerican Journal of Gastroenterology.
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
over 19 years ago
Pharmacy Technology Productsover 19 years ago
Tobacco Useover 19 years ago
Rx Product Newsover 19 years ago
OTC Product Newsover 19 years ago
can you READ theseRxs?over 19 years ago
Generic Times Product Newsover 19 years ago
compoundingHOTLINEover 19 years ago
Compounding for Pediatric Patientsover 19 years ago
Vaccinations: Current Research and Perceptionsover 19 years ago
Police and Drug TestingNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.










































































































































































































